TAK-020
oral covalent BTK inhibitor >80% BTK occupancy <5 mg (Ph. I dose esc.) from fragment-based screen of 11k cmpds Journal of Medicinal Chemistry Takeda, San Diego, CA, USA
Molecules of the Month - August 2021
Molecules of the Month
- berotralstat (BCX7353)
- "compound 20"
- CC-90005
- ASTX029
- soticlestat
- BMS-986318
- "compound 4f"
- MK-8262
- ZN-c3
- BAY-8400
- NBI-921352
- TAK-020
- AZD0284
- "compound 18n"